147 related articles for article (PubMed ID: 23849261)
1. Pain in adult patients with Pompe disease: a cross-sectional survey.
Güngör D; Schober AK; Kruijshaar ME; Plug I; Karabul N; Deschauer M; van Doorn PA; van der Ploeg AT; Schoser B; Hanisch F
Mol Genet Metab; 2013 Aug; 109(4):371-6. PubMed ID: 23849261
[TBL] [Abstract][Full Text] [Related]
2. Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease.
Umapathysivam K; Hopwood JJ; Meikle PJ
Clin Chim Acta; 2005 Nov; 361(1-2):191-8. PubMed ID: 15993875
[TBL] [Abstract][Full Text] [Related]
3. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
[TBL] [Abstract][Full Text] [Related]
4. The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease.
Laforêt P; Laloui K; Granger B; Hamroun D; Taouagh N; Hogrel JY; Orlikowski D; Bouhour F; Lacour A; Salort-Campana E; Penisson-Besnier I; Sacconi S; Zagnoli F; Chapon F; Eymard B; Desnuelle C; Pouget J;
Rev Neurol (Paris); 2013; 169(8-9):595-602. PubMed ID: 24008051
[TBL] [Abstract][Full Text] [Related]
5. Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale.
Hagemans ML; Laforêt P; Hop WJ; Merkies IS; Van Doorn PA; Reuser AJ; Van der Ploeg AT
Neuromuscul Disord; 2007 Jul; 17(7):537-43. PubMed ID: 17475490
[TBL] [Abstract][Full Text] [Related]
6. The genotype-phenotype correlation in Pompe disease.
Kroos M; Hoogeveen-Westerveld M; van der Ploeg A; Reuser AJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):59-68. PubMed ID: 22253258
[TBL] [Abstract][Full Text] [Related]
7. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
Young SP; Piraud M; Goldstein JL; Zhang H; Rehder C; Laforet P; Kishnani PS; Millington DS; Bashir MR; Bali DS
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):50-8. PubMed ID: 22252961
[TBL] [Abstract][Full Text] [Related]
8. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management.
Kishnani PS; Beckemeyer AA; Mendelsohn NJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):1-7. PubMed ID: 22253049
[TBL] [Abstract][Full Text] [Related]
9. [A retrospective study of six patients with late-onset Pompe disease].
Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
[TBL] [Abstract][Full Text] [Related]
10. 24-months results in two adults with Pompe disease on enzyme replacement therapy.
Vielhaber S; Brejova A; Debska-Vielhaber G; Kaufmann J; Feistner H; Schoenfeld MA; Awiszus F
Clin Neurol Neurosurg; 2011 Jun; 113(5):350-7. PubMed ID: 21477922
[TBL] [Abstract][Full Text] [Related]
11. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating.
Kroos M; Pomponio RJ; van Vliet L; Palmer RE; Phipps M; Van der Helm R; Halley D; Reuser A;
Hum Mutat; 2008 Jun; 29(6):E13-26. PubMed ID: 18425781
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy and fatigue in adults with Pompe disease.
Güngör D; de Vries JM; Brusse E; Kruijshaar ME; Hop WC; Murawska M; van den Berg LE; Reuser AJ; van Doorn PA; Hagemans ML; Plug I; van der Ploeg AT
Mol Genet Metab; 2013 Jun; 109(2):174-8. PubMed ID: 23603069
[TBL] [Abstract][Full Text] [Related]
13. [Adult form of Pompe disease].
Ziółkowska-Graca B; Kania A; Zwolińska G; Nizankowska-Mogilnicka E
Pneumonol Alergol Pol; 2008; 76(5):396-9. PubMed ID: 19003770
[TBL] [Abstract][Full Text] [Related]
14. Should patients with asymptomatic pompe disease be treated? A nationwide study in France.
Echaniz-Laguna A; Carlier RY; Laloui K; Carlier P; Salort-Campana E; Pouget J; Laforet P
Muscle Nerve; 2015 Jun; 51(6):884-9. PubMed ID: 25786784
[TBL] [Abstract][Full Text] [Related]
15. Exercise training in adults with Pompe disease: the effects on pain, fatigue, and functioning.
Favejee MM; van den Berg LE; Kruijshaar ME; Wens SC; Praet SF; Pim Pijnappel WW; van Doorn PA; Bussmann JB; van der Ploeg AT
Arch Phys Med Rehabil; 2015 May; 96(5):817-22. PubMed ID: 25499687
[TBL] [Abstract][Full Text] [Related]
16. Positive association between physical outcomes and patient-reported outcomes in late-onset Pompe disease: a cross sectional study.
Yuan M; Andrinopoulou ER; Kruijshaar ME; Lika A; Harlaar L; van der Ploeg AT; Rizopoulos D; van der Beek NAME
Orphanet J Rare Dis; 2020 Sep; 15(1):232. PubMed ID: 32883321
[TBL] [Abstract][Full Text] [Related]
17. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
[TBL] [Abstract][Full Text] [Related]
18. Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.
Kikuchi T; Yang HW; Pennybacker M; Ichihara N; Mizutani M; Van Hove JL; Chen YT
J Clin Invest; 1998 Feb; 101(4):827-33. PubMed ID: 9466978
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of patients with fibromyalgia in France and Germany.
Perrot S; Winkelmann A; Dukes E; Xu X; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
Int J Clin Pract; 2010 Jul; 64(8):1100-8. PubMed ID: 20497264
[TBL] [Abstract][Full Text] [Related]
20. Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations.
Palmer RE; Amartino HM; Niizawa G; Blanco M; Pomponio RJ; Chamoles NA
Neuromuscul Disord; 2007 Jan; 17(1):16-22. PubMed ID: 17056254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
